NCT05676515

Brief Summary

Under in vivo conditions, human gametes and embryos are exposed to fluids in the fallopian tubes, where fertilization occurs, and in the uterus, the site of embryonic implantation. The composition of these microenvironments is extremely complex and diverse. On the other hand, infertile couples who need in vitro fertilization treatments have their gametes and embryos cultured for a few days in commercial culture media. The composition of the media used in assisted reproduction laboratories varies according to the manufacturer and culture strategy. It is already known that the exposure of embryos to different concentrations of nutrients can affect the effectiveness of in vitro fertilization treatments, such as the fertilization rate, embryonic development speed, implantation rate, gestation, abortion, newborn weight, among other factors. Although these aspects are much discussed in the literature, there is still no consensus regarding the choice of a specific culture medium. Thus, the present study aims to evaluate the influence of three commercial culture media on the fertilization rate and embryonic quality through a prospective randomized clinical trial using sibling oocytes from patients undergoing in vitro fertilization cycles.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 10, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 22, 2022

Completed
18 days until next milestone

First Posted

Study publicly available on registry

January 9, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2023

Completed
Last Updated

February 28, 2024

Status Verified

February 1, 2024

Enrollment Period

5 months

First QC Date

December 22, 2022

Last Update Submit

February 26, 2024

Conditions

Keywords

culture mediafertilization

Outcome Measures

Primary Outcomes (1)

  • day three good quality embryo rate

    day three A/B embryos

    64-67 hours

Secondary Outcomes (1)

  • fertilization

    16-18 hours

Study Arms (3)

culture media of fabricant A

ACTIVE COMPARATOR

use of culture media of fabricant A

Other: culture media

culture media of fabricant B

ACTIVE COMPARATOR

use of culture media of fabricant B

Other: culture media

culture media of fabricant C

ACTIVE COMPARATOR

use of culture media of fabricant C

Other: culture media

Interventions

spliting of biological material and use of three culture media

culture media of fabricant Aculture media of fabricant Bculture media of fabricant C

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • IVF/ICSI cycles;
  • At least three oocytes retrieved;
  • Consent term signed;

You may not qualify if:

  • Less than three oocytes for fertilization.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Insemine

Porto Alegre, Rio Grande do Sul, 91330001, Brazil

Location

MeSH Terms

Conditions

Infertility, Female

Interventions

Culture Media

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesInfertility

Intervention Hierarchy (Ancestors)

Laboratory ChemicalsSpecialty Uses of ChemicalsChemical Actions and UsesEquipment and Supplies

Study Officials

  • João Sabino Cunha Filho, PhD

    Hospital de Clínicas de Porto Alegre

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 22, 2022

First Posted

January 9, 2023

Study Start

October 10, 2022

Primary Completion

March 1, 2023

Study Completion

March 31, 2023

Last Updated

February 28, 2024

Record last verified: 2024-02

Locations